<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Integrated Digital-Pathobiological Detection Theory of Alzheimer's Disease - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Theory Details for theory-2716</h1>

        <div class="section">
            <h2>Theory (General Information)</h2>
            <div class="info-section">
                <p><strong>ID:</strong> theory-2716</p>
                <p><strong>Name:</strong> Integrated Digital-Pathobiological Detection Theory of Alzheimer's Disease</p>
                <p><strong>Type:</strong> general</p>
                <p><strong>Theory Query:</strong> Build a theory of the cause of Alzheimer's disease and how it can be effectively detected, based on the following results.</p>
                <p><strong>Description:</strong> Alzheimer's disease can be most effectively detected and staged by integrating digital behavioral biomarkers (e.g., speech, language, functional activity) with molecular, imaging, and genetic data. Digital markers reflect early cognitive and functional changes that may precede or complement molecular biomarker changes, and their integration with biological data using advanced machine learning models enables earlier, more accurate, and scalable detection across the disease continuum.</p>
                <p><strong>Knowledge Cutoff Year:</strong> 2025</p>
                <p><strong>Knowledge Cutoff Month:</strong> 6</p>
                <p><strong>Base Model:</strong> openai/gpt-4.1-2025-04-14</p>
            </div>
        </div>

        <div class="section">
            <h2>Theory (Derived From)</h2>
            <p><strong>Derived From:</strong> <span class="empty-note">None</span></p>
            <p><strong>Change Log:</strong> <span class="empty-note">No change log entries.</span></p>
        </div>

        <div class="section">
            <h2>Evaluations of this Theory</h2>
            <p class="empty-note">No evaluations of this theory.</p>
        </div>

        <div class="section">
            <h2>Theory (Details)</h2>

            <h3>Theory Statements</h3>
            <h3>Statement 0: Digital-Pathobiological Synergy Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; individual &#8594; is_assessed_by &#8594; digital behavioral biomarkers (speech, language, functional activity, informant questionnaires)<span style="color: #888888;">, and</span></div>
        <div>&#8226; individual &#8594; is_assessed_by &#8594; molecular/imaging/genetic biomarkers</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; diagnostic_accuracy &#8594; is_greater_than &#8594; either modality alone</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Speech and language features (acoustic, linguistic, NLP-derived) can distinguish AD/MCI from controls and predict MMSE; informant-based and functional questionnaires (FAQ, QDRS, A-IADL-Q) have high sensitivity/specificity; multi-modal ML models integrating digital and biological data outperform single-modality models. <a href="../results/extraction-result-10013.html#e10013.11" class="evidence-link">[e10013.11]</a> <a href="../results/extraction-result-9962.html#e9962.3" class="evidence-link">[e9962.3]</a> <a href="../results/extraction-result-9962.html#e9962.5" class="evidence-link">[e9962.5]</a> <a href="../results/extraction-result-9977.html#e9977.16" class="evidence-link">[e9977.16]</a> <a href="../results/extraction-result-9957.html#e9957.3" class="evidence-link">[e9957.3]</a> <a href="../results/extraction-result-10014.html#e10014.10" class="evidence-link">[e10014.10]</a> <a href="../results/extraction-result-10013.html#e10013.12" class="evidence-link">[e10013.12]</a> <a href="../results/extraction-result-9973.html#e9973.4" class="evidence-link">[e9973.4]</a> <a href="../results/extraction-result-10015.html#e10015.6" class="evidence-link">[e10015.6]</a> <a href="../results/extraction-result-9994.html#e9994.5" class="evidence-link">[e9994.5]</a> <a href="../results/extraction-result-10017.html#e10017.6" class="evidence-link">[e10017.6]</a> <a href="../results/extraction-result-9990.html#e9990.9" class="evidence-link">[e9990.9]</a> <a href="../results/extraction-result-9990.html#e9990.16" class="evidence-link">[e9990.16]</a> <a href="../results/extraction-result-9986.html#e9986.8" class="evidence-link">[e9986.8]</a> <a href="../results/extraction-result-9999.html#e9999.19" class="evidence-link">[e9999.19]</a> <a href="../results/extraction-result-10048.html#e10048.5" class="evidence-link">[e10048.5]</a> <a href="../results/extraction-result-9978.html#e9978.9" class="evidence-link">[e9978.9]</a> </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
            <p><strong>Explanation:</strong> While digital biomarkers and multi-modal models are being explored, the explicit law-like statement of synergy and early detection is novel.</p>            <p><strong>What Already Exists:</strong> Digital biomarkers and multi-modal integration are emerging in AD research.</p>            <p><strong>What is Novel:</strong> This law formalizes the synergistic effect of combining digital and biological markers, and asserts that digital markers can provide early, scalable, and complementary information for detection.</p>
            <p><strong>References:</strong> <ul>
    <li>Eyigoz et al. (2020) Linguistic markers predict onset of Alzheimer's disease [Digital biomarkers]</li>
    <li>Haulcy et al. (2022) Speech-based detection of Alzheimer's disease [Speech ML]</li>
    <li>Westman et al. (2012) Combining MRI and CSF measures [Multi-modal integration]</li>
</ul>
            <h3>Statement 1: Early Digital Marker Law (qualitative)</h3>
<table>
<thead> 
<tr><th style="width: 10%;">Condition</th><th style="width: 90%;">Details</th></tr>
</thead>
<tbody>
<tr>
    <td><strong>IF</strong></td>
    <td>
        <div>&#8226; individual &#8594; is_in_preclinical_or_early_stage_AD &#8594; True</div>
    </td>
</tr>
<tr>
    <td><strong>THEN</strong></td>
    <td>
        <div>&#8226; digital behavioral biomarkers &#8594; become_abnormal &#8594; before or in parallel with molecular/imaging biomarkers</div>
    </td>
</tr>
</tbody>
</table>
            <h4>Supporting Evidence for this Law</h4>
<ol>
    <li>Speech/language features, informant-based functional decline (FAQ, A-IADL-Q), and subtle cognitive test changes can be detected in MCI and even SCD stages, sometimes before overt biomarker changes; digital markers are sensitive to early functional and cognitive decline. <a href="../results/extraction-result-10013.html#e10013.11" class="evidence-link">[e10013.11]</a> <a href="../results/extraction-result-9962.html#e9962.3" class="evidence-link">[e9962.3]</a> <a href="../results/extraction-result-9977.html#e9977.16" class="evidence-link">[e9977.16]</a> <a href="../results/extraction-result-9957.html#e9957.3" class="evidence-link">[e9957.3]</a> <a href="../results/extraction-result-9990.html#e9990.9" class="evidence-link">[e9990.9]</a> <a href="../results/extraction-result-9990.html#e9990.16" class="evidence-link">[e9990.16]</a> <a href="../results/extraction-result-9986.html#e9986.8" class="evidence-link">[e9986.8]</a> <a href="../results/extraction-result-9999.html#e9999.19" class="evidence-link">[e9999.19]</a> <a href="../results/extraction-result-9989.html#e9989.9" class="evidence-link">[e9989.9]</a> <a href="../results/extraction-result-9989.html#e9989.8" class="evidence-link">[e9989.8]</a> <a href="../results/extraction-result-9989.html#e9989.13" class="evidence-link">[e9989.13]</a> <a href="../results/extraction-result-9986.html#e9986.7" class="evidence-link">[e9986.7]</a> <a href="../results/extraction-result-9980.html#e9980.6" class="evidence-link">[e9980.6]</a> </li>
</ol>            <h4>Existing Law Comparison</h4>
            <p><strong>Likely Classification:</strong> <span style="color: orange; font-weight: bold;">somewhat-related-to-existing</span></p>
            <p><strong>Explanation:</strong> The early detection potential of digital markers is being explored, but their formal equivalence or precedence to molecular markers is a novel assertion.</p>            <p><strong>What Already Exists:</strong> Early cognitive and functional changes are recognized in prodromal AD.</p>            <p><strong>What is Novel:</strong> This law asserts that digital markers (speech, language, functional activity) can be as early or earlier than molecular biomarkers, and are scalable for population-level screening.</p>
            <p><strong>References:</strong> <ul>
    <li>Eyigoz et al. (2020) Linguistic markers predict onset of Alzheimer's disease [Digital biomarkers]</li>
    <li>Suárez-Araujo et al. (2021) ANN for MCI detection [Functional/cognitive scales]</li>
</ul>
            <h3>New Predictions (Likely outcome)</h3>
            <ol>
                <li>Automated speech and language analysis will identify individuals at risk for AD before clinical diagnosis or biomarker positivity.</li>
                <li>Combining digital behavioral data with molecular/imaging/genetic data in ML models will yield higher sensitivity and specificity for early AD detection than either alone.</li>
                <li>Informant-based functional questionnaires will detect subtle decline in MCI and SCD stages, correlating with future biomarker changes.</li>
            </ol>
            <h3>New Predictions (Unknown outcome/high-entropy)</h3>
            <ol>
                <li>Passive digital monitoring (e.g., smartphone, wearable sensors) will detect preclinical AD in asymptomatic individuals before any molecular biomarker abnormality.</li>
                <li>Digital biomarkers will enable remote, large-scale, low-cost screening for AD risk in the general population, identifying high-risk individuals for further biomarker testing.</li>
                <li>Integration of digital and biological data will allow for individualized prediction of disease trajectory and response to interventions.</li>
            </ol>
            <h3>Negative Experiments</h3>
            <ol>
                <li>If digital behavioral markers do not precede or add predictive value to molecular/imaging biomarkers, the early digital marker law would be challenged.</li>
                <li>If multi-modal integration of digital and biological data does not improve detection accuracy, the synergy law would be undermined.</li>
                <li>If digital markers are not robust across languages, cultures, and recording conditions, their generalizability would be limited.</li>
            </ol>
            <h3>Unaccounted for Evidence</h3>
<ol>
    <li>Cases where digital markers are normal but molecular biomarkers are abnormal (e.g., preclinical amyloid-positive individuals with preserved function). <a href="../results/extraction-result-9991.html#e9991.0" class="evidence-link">[e9991.0]</a> <a href="../results/extraction-result-10001.html#e10001.7" class="evidence-link">[e10001.7]</a> <a href="../results/extraction-result-10014.html#e10014.0" class="evidence-link">[e10014.0]</a> <a href="../results/extraction-result-10014.html#e10014.2" class="evidence-link">[e10014.2]</a> </li>
</ol>            <h3>Existing Theory Comparison</h3>
            <p><strong>Likely Classification:</strong> somewhat-related-to-existing</p>
            <p><strong>Explanation:</strong> While digital biomarkers are being explored, the explicit law-like structure and assertion of early and synergistic detection is a novel synthesis.</p>
            <p><strong>References:</strong> <ul>
    <li>Eyigoz et al. (2020) Linguistic markers predict onset of Alzheimer's disease [Digital biomarkers]</li>
    <li>Haulcy et al. (2022) Speech-based detection of Alzheimer's disease [Speech ML]</li>
    <li>Westman et al. (2012) Combining MRI and CSF measures [Multi-modal integration]</li>
</ul>
        </div>

        <div class="section">
            <h2>Theory Components (Debug)</h2>
            <pre><code>{
    "theory_name": "Integrated Digital-Pathobiological Detection Theory of Alzheimer's Disease",
    "theory_description": "Alzheimer's disease can be most effectively detected and staged by integrating digital behavioral biomarkers (e.g., speech, language, functional activity) with molecular, imaging, and genetic data. Digital markers reflect early cognitive and functional changes that may precede or complement molecular biomarker changes, and their integration with biological data using advanced machine learning models enables earlier, more accurate, and scalable detection across the disease continuum.",
    "theory_statements": [
        {
            "law": {
                "law_name": "Digital-Pathobiological Synergy Law",
                "if": [
                    {
                        "subject": "individual",
                        "relation": "is_assessed_by",
                        "object": "digital behavioral biomarkers (speech, language, functional activity, informant questionnaires)"
                    },
                    {
                        "subject": "individual",
                        "relation": "is_assessed_by",
                        "object": "molecular/imaging/genetic biomarkers"
                    }
                ],
                "then": [
                    {
                        "subject": "diagnostic_accuracy",
                        "relation": "is_greater_than",
                        "object": "either modality alone"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Speech and language features (acoustic, linguistic, NLP-derived) can distinguish AD/MCI from controls and predict MMSE; informant-based and functional questionnaires (FAQ, QDRS, A-IADL-Q) have high sensitivity/specificity; multi-modal ML models integrating digital and biological data outperform single-modality models.",
                        "uuids": [
                            "e10013.11",
                            "e9962.3",
                            "e9962.5",
                            "e9977.16",
                            "e9957.3",
                            "e10014.10",
                            "e10013.12",
                            "e9973.4",
                            "e10015.6",
                            "e9994.5",
                            "e10017.6",
                            "e9990.9",
                            "e9990.16",
                            "e9986.8",
                            "e9999.19",
                            "e10048.5",
                            "e9978.9"
                        ]
                    }
                ],
                "qual_or_quant": "qualitative",
                "existing_law": {
                    "what_already_exists": "Digital biomarkers and multi-modal integration are emerging in AD research.",
                    "what_is_novel": "This law formalizes the synergistic effect of combining digital and biological markers, and asserts that digital markers can provide early, scalable, and complementary information for detection.",
                    "classification_explanation": "While digital biomarkers and multi-modal models are being explored, the explicit law-like statement of synergy and early detection is novel.",
                    "likely_classification": "somewhat-related-to-existing",
                    "references": [
                        "Eyigoz et al. (2020) Linguistic markers predict onset of Alzheimer's disease [Digital biomarkers]",
                        "Haulcy et al. (2022) Speech-based detection of Alzheimer's disease [Speech ML]",
                        "Westman et al. (2012) Combining MRI and CSF measures [Multi-modal integration]"
                    ]
                }
            }
        },
        {
            "law": {
                "law_name": "Early Digital Marker Law",
                "if": [
                    {
                        "subject": "individual",
                        "relation": "is_in_preclinical_or_early_stage_AD",
                        "object": "True"
                    }
                ],
                "then": [
                    {
                        "subject": "digital behavioral biomarkers",
                        "relation": "become_abnormal",
                        "object": "before or in parallel with molecular/imaging biomarkers"
                    }
                ],
                "supporting_evidence": [
                    {
                        "text": "Speech/language features, informant-based functional decline (FAQ, A-IADL-Q), and subtle cognitive test changes can be detected in MCI and even SCD stages, sometimes before overt biomarker changes; digital markers are sensitive to early functional and cognitive decline.",
                        "uuids": [
                            "e10013.11",
                            "e9962.3",
                            "e9977.16",
                            "e9957.3",
                            "e9990.9",
                            "e9990.16",
                            "e9986.8",
                            "e9999.19",
                            "e9989.9",
                            "e9989.8",
                            "e9989.13",
                            "e9986.7",
                            "e9980.6"
                        ]
                    }
                ],
                "qual_or_quant": "qualitative",
                "existing_law": {
                    "what_already_exists": "Early cognitive and functional changes are recognized in prodromal AD.",
                    "what_is_novel": "This law asserts that digital markers (speech, language, functional activity) can be as early or earlier than molecular biomarkers, and are scalable for population-level screening.",
                    "classification_explanation": "The early detection potential of digital markers is being explored, but their formal equivalence or precedence to molecular markers is a novel assertion.",
                    "likely_classification": "somewhat-related-to-existing",
                    "references": [
                        "Eyigoz et al. (2020) Linguistic markers predict onset of Alzheimer's disease [Digital biomarkers]",
                        "Suárez-Araujo et al. (2021) ANN for MCI detection [Functional/cognitive scales]"
                    ]
                }
            }
        }
    ],
    "new_predictions_likely": [
        "Automated speech and language analysis will identify individuals at risk for AD before clinical diagnosis or biomarker positivity.",
        "Combining digital behavioral data with molecular/imaging/genetic data in ML models will yield higher sensitivity and specificity for early AD detection than either alone.",
        "Informant-based functional questionnaires will detect subtle decline in MCI and SCD stages, correlating with future biomarker changes."
    ],
    "new_predictions_unknown": [
        "Passive digital monitoring (e.g., smartphone, wearable sensors) will detect preclinical AD in asymptomatic individuals before any molecular biomarker abnormality.",
        "Digital biomarkers will enable remote, large-scale, low-cost screening for AD risk in the general population, identifying high-risk individuals for further biomarker testing.",
        "Integration of digital and biological data will allow for individualized prediction of disease trajectory and response to interventions."
    ],
    "negative_experiments": [
        "If digital behavioral markers do not precede or add predictive value to molecular/imaging biomarkers, the early digital marker law would be challenged.",
        "If multi-modal integration of digital and biological data does not improve detection accuracy, the synergy law would be undermined.",
        "If digital markers are not robust across languages, cultures, and recording conditions, their generalizability would be limited."
    ],
    "unaccounted_for": [
        {
            "text": "Cases where digital markers are normal but molecular biomarkers are abnormal (e.g., preclinical amyloid-positive individuals with preserved function).",
            "uuids": [
                "e9991.0",
                "e10001.7",
                "e10014.0",
                "e10014.2"
            ]
        }
    ],
    "conflicting_evidence": [
        {
            "text": "Some studies report lower accuracy for MCI detection from speech than for AD, and variable performance across languages and datasets.",
            "uuids": [
                "e9978.9",
                "e9962.3",
                "e9957.3"
            ]
        }
    ],
    "special_cases": [
        "Individuals with high cognitive reserve may show delayed digital marker changes despite underlying pathology.",
        "Non-AD dementias or comorbidities may confound digital marker specificity."
    ],
    "existing_theory": {
        "what_already_exists": "Digital biomarkers and multi-modal integration are emerging but not yet standard in AD detection.",
        "what_is_novel": "This theory formalizes the synergistic and potentially early role of digital behavioral markers, and their integration with biological data for optimal detection.",
        "classification_explanation": "While digital biomarkers are being explored, the explicit law-like structure and assertion of early and synergistic detection is a novel synthesis.",
        "likely_classification": "somewhat-related-to-existing",
        "references": [
            "Eyigoz et al. (2020) Linguistic markers predict onset of Alzheimer's disease [Digital biomarkers]",
            "Haulcy et al. (2022) Speech-based detection of Alzheimer's disease [Speech ML]",
            "Westman et al. (2012) Combining MRI and CSF measures [Multi-modal integration]"
        ]
    },
    "theory_type_general_specific": "general",
    "reflected_from_theory_index": 0,
    "version": "built-theory-from-results-single-theory-reflection2-nov14-2025",
    "type": "general"
}</code></pre>
        </div>
    </div>
</body>
</html>